跳至主要内容
临床试验/NCT06342856
NCT06342856招募中早期 1 期

Evaluation of Treatment With Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile Men With Idiopathic Oligoasthenoteratospermia a Placebo Controlled Clinical Trial

Ain Shams University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年6月15日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
招募中
入组人数
120
试验地点
1
主要终点
Changes in Semen analysis parameters compared to baseline

研究概览

简要总结

Evaluation of treatment with Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile men with Idiopathic Oligoasthenoteratospermia

详细描述

Evaluation of treatment with Coenzyme Q10 and L-Carnitine on Semen Parameters in Infertile men with Idiopathic Oligoasthenoteratospermia a placebo controlled clinical trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • of in¬fertility of 1 year or more without the use of contraception

排除标准

  • o Active genital infections.
  • Patients with ejaculatory dysfunction
  • Azoospermia

研究组 & 干预措施

Group 1

Active Comparator

will receive a daily dose of 200 mg of CoQ10 for 3 months

干预措施: co enzyme Q10 , L- Carnitine (Drug)

Group 2

Active Comparator

will receive L-carnitine 1 tablet per day orally for 3 months

干预措施: co enzyme Q10 , L- Carnitine (Drug)

Group 3

Active Comparator

will receive combination of a daily dose of 200 mg of CoQ10 and 1 tablet of L-carnitine for 3 months

干预措施: co enzyme Q10 , L- Carnitine (Drug)

Group 4

Placebo Comparator

will receive a placebo for 3 months

干预措施: co enzyme Q10 , L- Carnitine (Drug)

结局指标

主要结局

Changes in Semen analysis parameters compared to baseline

时间窗: 6 months

Changes in Semen analysis parameters compared to baseline

次要结局

  • Serum hormone levels ([FSH], [LH], testosterone, and prolactin) levels compared to baseline and Cost analysis(6 moths)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Treatment With Coenzyme Q10 and... | 临床试验